Your browser doesn't support javascript.
loading
Chimeric Antigen Receptor-modified T cells targeting EphA2 for the immunotherapy of paediatric bone tumours.
Hsu, Kenneth; Middlemiss, Shiloh; Saletta, Federica; Gottschalk, Stephen; McCowage, Geoffrey B; Kramer, Belinda.
Afiliação
  • Hsu K; Children's Cancer Research Unit, Kid's Research, The Children's Hospital at Westmead, Westmead, NSW, 2145, Australia.
  • Middlemiss S; Children's Cancer Research Unit, Kid's Research, The Children's Hospital at Westmead, Westmead, NSW, 2145, Australia.
  • Saletta F; Children's Cancer Research Unit, Kid's Research, The Children's Hospital at Westmead, Westmead, NSW, 2145, Australia.
  • Gottschalk S; Department of Bone Marrow Transplant and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • McCowage GB; Children's Cancer Centre, The Children's Hospital at Westmead, Westmead, NSW, 2145, Australia.
  • Kramer B; Children's Cancer Research Unit, Kid's Research, The Children's Hospital at Westmead, Westmead, NSW, 2145, Australia. Belinda.Kramer@health.nsw.gov.au.
Cancer Gene Ther ; 28(3-4): 321-334, 2021 04.
Article em En | MEDLINE | ID: mdl-32873870
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Linfócitos T / Imunoterapia Adotiva / Receptor EphA2 Tipo de estudo: Guideline Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Linfócitos T / Imunoterapia Adotiva / Receptor EphA2 Tipo de estudo: Guideline Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article